WeVote
Log In

Bill

Bill

HB 6106

AN ACT REQUIRING PERIODIC TESTING OF ABLE-BODIED BENEFICIARIES OF PUBLIC ASSISTANCE FOR ILLICIT DRUG USE.

2025 Regular Session Introduced by Joe Hoxha

Connecticut bill would require regular drug testing of able-bodied public assistance recipients to maintain benefit eligibility, raising constitutional and cost concerns.

REF. TO JOINT COMM. ON Human Services
#drugtesting #publicwelfare
0
WeVote Research Nonpartisan
Bill Summary · HB 6106

Legislative bill overview

HB 6106 would mandate periodic drug testing for able-bodied recipients of Connecticut public assistance programs. The bill requires these beneficiaries to submit to illicit drug screening at regular intervals as a condition of receiving benefits. Failure to comply or positive test results would presumably affect benefit eligibility.

Why is this important

Drug testing of welfare recipients affects millions of low-income individuals' access to survival resources and raises questions about program administration costs, constitutional concerns, and evidence of effectiveness. The policy reflects broader debates about government surveillance, personal privacy, and assumptions about substance abuse prevalence among assistance recipients, with real consequences for food security, housing, and healthcare access.

Potential points of contention

  • Constitutionality and privacy: Drug testing without individualized suspicion may violate Fourth Amendment protections against unreasonable searches, and state constitutions often provide stronger privacy protections
  • Cost-benefit analysis: Program administration, testing expenses, and handling of positive results may exceed savings from reduced benefits, a pattern observed in other states' similar programs
  • Stigma and effectiveness: The bill assumes substance abuse is prevalent among this population without citation; research from other states shows relatively low positive rates, raising questions about whether testing targets the actual problem or reinforces stereotypes
  • Practical implementation gaps: The bill doesn't specify what "periodic" means, how testing is funded, which substances are tested, or how results are handled, creating administrative ambiguity

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.